Sun Pharma Eyes Organon In What Could Be India Pharma’s Biggest Cross-Border Deal: Report

All NewsJanuary 20, 2026

Sun Pharma is evaluating a potential $10 billion acquisition of Organon, a move that could become India’s largest cross-border pharma deal.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent